1. 1010. Effective Management of HIV in Rural Georgia Using Telemedicine. (31st December 2020) Authors: Lawal, Folake J; Rao, Arni S R Srinivasa; Vazquez, Jose A Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial. (31st December 2020) Authors: Bulpa, Pierre; Rahav, Galia; Oren, Ilana; Aoun, Mickaël; Thompson, George R; Pappas, Peter; Kullberg, Bart Jan; Vazquez, Jose A; Barbat, Sara; Wedel, Pamela; Schlamm, Haran T; Hodges, Michael Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI). (4th December 2021) Authors: Pappas, Peter G; Cornely, Oliver; Koehler, Philipp; McCarty, Todd P; Alexander, Barbara D; Miller, Rachel; Vazquez, Jose A; Sanders, John W; Morse, Caryn; Ostrosky-Zeichner, Luis; Krause, Robert; Prattes, Jürgen; Spec, Andrej; Rautemaa-Richardson, Riina; Bazaz, Rohit; Walsh, Thomas J; Marty, Fran... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI). (31st December 2020) Authors: Alexander, Barbara D; Cornely, Oliver; Pappas, Peter; Miller, Rachel; Vazquez, Jose A; Ostrosky-Zeichner, Luis; Spec, Andrej; Rautemaa-Richardson, Riina; Krause, Robert; Thompson III, George R; Morse, Caryn; Sanders, John W; Andes, David; Andes, David; Lyon, George; Marty, Francisco M; Silverman,... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1291. PROVE (Retrospective Cefiderocol Chart Review) Study of Real-World Outcomes and Safety in the Treatment of Patients with Gram-negative Bacterial Infections in the US and Europe. (4th December 2021) Authors: Marcella, Stephen; Chopra, Teena; Chopra, Teena; Vazquez, Jose A; Smoke, Steven; Shields, Ryan K; van Duin, David Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1291. PROVE (Retrospective Cefiderocol Chart Review) Study of Real-World Outcomes and Safety in the Treatment of Patients with Gram-negative Bacterial Infections in the US and Europe. (4th December 2021) Authors: Marcella, Stephen; Chopra, Teena; Chopra, Teena; Vazquez, Jose A; Smoke, Steven; Shields, Ryan K; van Duin, David Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial. (31st December 2020) Authors: Pappas, Peter; Kullberg, Bart Jan; Vazquez, Jose A; Oren, Ilana; Rahav, Galia; Aoun, Mickaël; Bulpa, Pierre; Ben-Ami, Ronen; Ferrer, Ricard; McCarty, Todd P; Thompson III, George R; Barbat, Sara; Wedel, Pamela; Oborska, Iwonka; Schlamm, Haran T; Hodges, Michael Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 231. Outcomes by Baseline Pathogen and Susceptibility in the ReSTORE Phase 3 Trial of Rezafungin Once Weekly Compared with Caspofungin Once Daily in Patients with Candidemia and/or Invasive Candidiasis. (15th December 2022) Authors: Thompson, George R; Soriano, Alex; Cornely, Oliver A; Kullberg, Bart-Jan; Kollef, Marin; Vazquez, Jose A; Das, Anita F; Locke, Jeffrey B; Sandison, Taylor; Pappas, Peter G Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 343. RURAL-COVID-19 Trial: Retrospective Analysis of COVID-19 Coinfections in Hospitalized Urban and Rural Adults. (4th December 2021) Authors: Hamilton, Caroline; Frazier, Heather; Vazquez, Jose A Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 391. Small Towns, Big Cities: Rural and Urban Disparities Among Hospitalized Patients with COVID-19. (4th December 2021) Authors: Hamilton, Caroline; Ayyala, Deepak Nag; Walsh, David; Bramwell, Christian-Jevon; Walker, Christopher; Dib, Rita Wilson; Gosse, Jessica; Ladak, Amber F; Morissette, Patricia; Rao, Arni S R Srinivasa; Chao, Andrew; Vazquez, Jose A Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗